The U.S. is ready to roll out the COVID vaccine once it’s approved for kids age 5-11

toggle caption

hide caption

. Justin Sullivan/Getty Images

Safeway pharmacist Ashley McGee fills a syringe with the Pfizer COVID-19 booster vaccination at a vaccination booster shot center on Oct. 1, in San Rafael, Calif

Justin Sullivan/Getty Images

The White House stated on Wednesday that it is prepared to quickly roll out COVID-19 vaccines for kids ages 5 to 11, if the Pfizer-BioNTech vaccine for that age group is licensed by the Food and Drug Administration and recommended by the Centers for Disease Control and Prevention. The vaccine could be cleared for use in kids ages 5 to 11 within a couple of weeks, officials said. White House officials stated they were revealing the strategy to inoculate kids ages 5 to 11 prior to the vaccine was authorized for that age group so they could be “operationally prepared” to deploy the doses as soon as the approval came.

Under the plan, the administration will work with state and regional leaders to make the vaccine readily available at more than 25,000 pediatricians offices and primary care sites and 100 kidss health center systems as well as pharmacies, schools and neighborhood health. “Thats why were making sure that its trusted messengers with clinical trustworthiness who go out there and talk about these vaccines,” Murthy said.

. Justin Sullivan/Getty Images

The vaccine could be cleared for use in children ages 5 to 11 within a couple of weeks, officials stated. White House officials said they were revealing the strategy to inoculate children ages 5 to 11 prior to the vaccine was authorized for that age group so they could be “operationally ready” to release the doses as soon as the approval came.

Safeway pharmacist Ashley McGee fills a syringe with the Pfizer COVID-19 booster vaccination at a vaccination booster shot clinic on Oct. 1, in San Rafael, Calif

The White House said on Wednesday that it is all set to rapidly roll out COVID-19 vaccines for kids ages 5 to 11, if the Pfizer-BioNTech vaccine for that age is authorized by the Food and Drug Administration and advised by the Centers for Disease Control and Prevention. The administration has bought enough dosages for all 28 million children in that age group and will provide it in smaller packages with necessary products like smaller sized needles to make it much easier to get to doctors, pediatricians and neighborhood health centers, Biden administration authorities said. “Should the FDA and CDC license the vaccine, we will be all set to get shots in arms,” said White House coronavirus action planner Jeff Zients throughout a news instruction Wednesday early morning.

Leave a Reply

Your email address will not be published. Required fields are marked *